The Enzyme Experts
0
0
Viral Vector Production

DNA Removal for AAV and Adenoviral Vectors

APPLICATION overview, CHALLENGES AND SOLUTION

See enzymes for

For Detailed Info Including:
  • Product overview
  • Performance data & figures
  • Specifications
  • Documents
  • FAQs
  • Ordering Info
  • Protocols
  • Publications

Application Overview

For AAV, typical recovery is around 40% meaning up to 60% of produced viral vector is lost in downstream processing, and host-cell chromatin left by conventional nucleases is a hidden driver of that loss.

Effective host-cell DNA removal depends on the conditions of your AAV or adenoviral process. M-SAN HQ removes chromatin-associated DNA at physiological salt, while SAN HQ remains active at high salt, where salt can also help reduce capsid aggregation.

See enzymes for

DNA Removal for AAV and Adenoviral Vectors
No items found.
No items found.
For Detailed Info Including:
  • Product overview
  • Performance data & figures
  • Specifications
  • Documents
  • FAQs
  • Ordering Info
  • Protocols
  • Publications

Application Overview

For AAV, typical recovery is around 40% meaning up to 60% of produced viral vector is lost in downstream processing, and host-cell chromatin left by conventional nucleases is a hidden driver of that loss.

Effective host-cell DNA removal depends on the conditions of your AAV or adenoviral process. M-SAN HQ removes chromatin-associated DNA at physiological salt, while SAN HQ remains active at high salt, where salt can also help reduce capsid aggregation.

The Challenges These Enzymes Address

Why conventional nucleases struggle with chromatin in AAV processing

Why host-cell DNA remains protected within chromatin

Host-cell DNA is not always present as free DNA. Much of it can be locked away in chromatin, wrapped around histones and packed into compact structures that shield the DNA from nuclease access. That makes chromatin-associated DNA the tougher target. Effective host-cell DNA removal therefore depends not only on degrading free DNA, but also on reaching and digesting DNA protected within chromatin.

This is what makes chromatin easy to overlook: Standard assays for measuring residual DNA only read accessible DNA. As a result, a sample can pass a release assay while chromatin-associated DNA remains in the process stream.

Diagram showing DNA wrapped around histones to form compact chromatin fibers
Fig 1. Chromatin is DNA complexed with histones in compact nucleoprotein fibers.

How high salt exposes chromatin but reduces conventional nuclease activity

For non-enveloped vectors, high salt can work in your favor in two ways. As ionic strength increases, it screens the electrostatic interactions between negatively charged DNA and positively charged histones. From around 400 mM NaCl, nucleosomes begin to loosen, making chromatin more accessible to nuclease digestion.

At the same time, higher salt can reduce vector aggregation and release DNA trapped within aggregates. This is why many AAV and adenovirus processes use lysis conditions around 500 mM NaCl, with some operating at even higher concentrations.

The challenge is nuclease activity. Conventional S. marcescens nucleases lose more than half of their activity in cell culture media and become nearly inactive at the high-salt conditions where chromatin is most accessible.

This creates a process trade-off: the conditions that help expose chromatin can also prevent a conventional nuclease from efficiently digesting it. As a result, efficient DNA clearance may require process adjustments such as dilution or desalting, increased enzyme concentrations, or adding an extra nuclease treatment later in the process..

Graph comparing the relative activity of nucleases across different salt concentrations

Fig 2. Relative activity of nucleases across salt concentrations

Relative activity of commonly used nucleases across salt concentrations. Conventional nucleases (S. marcescens) lose function in cell culture media and are near nonfunctional at de-aggregating salt. The salt-active alternatives are shown in Figure 4.

ArcticZymes testing conditions →

How residual chromatin affects AAV and Adenovirus recovery and purification

Chromatin fragments that survive nuclease treatment can persist through downstream processing alongside virus particles, with effects across the workflow:

  • Aggregation that can compromise vector quality and process consistency
  • Filter fouling that can make clarification and downstream processing more difficult
  • Variable recovery that can reduce process yield and reproducibility
  • Residual DNA risk if chromatin-associated DNA is not fully removed or detected

Effective chromatin clearance therefore matters not only for downstream process performance, but also for controlling residual DNA.

Electron micrograph showing chromatin fragments alongside virus particles

Fig 3. Chromatin fragments persist through conventional nuclease treatment and downstream processing, co-localizing with virus particles.

Image courtesy acib. Adapted from Pereira Aguilar et al., J. Chromatogr. A 1627 (2020) 461378.

View publication →

THE PROBLEM These ENZYME SOLVES

Why conventional nucleases struggle with chromatin in AAV processing

Why host-cell DNA remains protected within chromatin

Host-cell DNA is not always present as free DNA. Much of it can be locked away in chromatin, wrapped around histones and packed into compact structures that shield the DNA from nuclease access. That makes chromatin-associated DNA the tougher target. Effective host-cell DNA removal therefore depends not only on degrading free DNA, but also on reaching and digesting DNA protected within chromatin.

This is what makes chromatin easy to overlook: Standard assays for measuring residual DNA only read accessible DNA. As a result, a sample can pass a release assay while chromatin-associated DNA remains in the process stream.

Diagram showing DNA wrapped around histones to form compact chromatin fibers
Fig 1. Chromatin is DNA complexed with histones in compact nucleoprotein fibers.

How high salt exposes chromatin but reduces conventional nuclease activity

For non-enveloped vectors, high salt can work in your favor in two ways. As ionic strength increases, it screens the electrostatic interactions between negatively charged DNA and positively charged histones. From around 400 mM NaCl, nucleosomes begin to loosen, making chromatin more accessible to nuclease digestion.

At the same time, higher salt can reduce vector aggregation and release DNA trapped within aggregates. This is why many AAV and adenovirus processes use lysis conditions around 500 mM NaCl, with some operating at even higher concentrations.

The challenge is nuclease activity. Conventional S. marcescens nucleases lose more than half of their activity in cell culture media and become nearly inactive at the high-salt conditions where chromatin is most accessible.

This creates a process trade-off: the conditions that help expose chromatin can also prevent a conventional nuclease from efficiently digesting it. As a result, efficient DNA clearance may require process adjustments such as dilution or desalting, increased enzyme concentrations, or adding an extra nuclease treatment later in the process..

Graph comparing the relative activity of nucleases across different salt concentrations

Fig 2. Relative activity of nucleases across salt concentrations

Relative activity of commonly used nucleases across salt concentrations. Conventional nucleases (S. marcescens) lose function in cell culture media and are near nonfunctional at de-aggregating salt. The salt-active alternatives are shown in Figure 4.

ArcticZymes testing conditions →

How residual chromatin affects AAV and Adenovirus recovery and purification

Chromatin fragments that survive nuclease treatment can persist through downstream processing alongside virus particles, with effects across the workflow:

  • Aggregation that can compromise vector quality and process consistency
  • Filter fouling that can make clarification and downstream processing more difficult
  • Variable recovery that can reduce process yield and reproducibility
  • Residual DNA risk if chromatin-associated DNA is not fully removed or detected

Effective chromatin clearance therefore matters not only for downstream process performance, but also for controlling residual DNA.

Electron micrograph showing chromatin fragments alongside virus particles

Fig 3. Chromatin fragments persist through conventional nuclease treatment and downstream processing, co-localizing with virus particles.

Image courtesy acib. Adapted from Pereira Aguilar et al., J. Chromatogr. A 1627 (2020) 461378.

View publication →
Fig .

The Solution

Nuclease for your AAV and Adenovirus process conditions

Adapt the nuclease to your process,not your process to the nuclease. For non-enveloped vectors there are two ways to clear chromatin, and the right one depends on whether high salt benefits your process.

Graph comparing the relative activity of nucleases across different salt concentrations

Fig 4.The two salt-active nucleases are tuned to the two salt regimes.

M-SAN HQ peaks in the physiological-salt range of cell media; SAN HQ gains activity as salt rises into the de-aggregating range. Between them, at around 225–400 mM, the curves cross and the better choice depends on temperature and pH. Compare with the conventional nucleases in Figure 2.

ArcticZymes testing conditions →

Nuclease Selection Guide

Physiological salt

M-SAN HQ

Choose when increasing salt brings no benefit to your process.

  • Lower or moderate aggregation, often including AAV8*
  • Physiological salt, with no additional salt or buffer change
  • Best fit: pH 7.2–7.5 at 37 °C
225–400 mM NaCl

Test both

At intermediate salt, temperature and pH become more important.

  • SAN HQ: favors cold or overnight processing, including temperatures down to approximately 5 °C
  • M-SAN HQ: favors warmer processing around pH 7.2–7.5 at 37 °C
  • Not an obvious choice? Test both under your own process conditions
High salt

SAN HQ

Choose when high salt already helps reduce capsid aggregation.

  • Higher aggregation tendency, often including AAV2*
  • High-salt processing where salt helps expose chromatin
  • Best fit: remains active up to approximately 700 mM NaCl

*Serotype guidance reflects typical process behavior rather than a rule. Where process conditions sit between these ranges, evaluate both enzymes under your own conditions.

Whichever route you choose, the goal is the same

Both M-SAN HQ and SAN HQ break down chromatin into smaller fragments that are easier to remove downstream.

Support downstream clearance

Smaller chromatin fragments can clear during filtration and TFF rather than contributing to filter fouling or co-purification.

Fit your harvest approach

Use during cell lysis or in supernatant-based workflows.

Compatible with lysis conditions

Both enzymes are compatible with commonly used lysis detergents.

‍

Evidence for host-cell DNA removal with SAN HQ

A viral vector core at a major US academic center compared its previous process, using a conventional nuclease at physiological salt, with SAN HQ at 500 mM NaCl. SAN HQ left less residual DNA with less nuclease, without loss of vector yield or activity, independent of serotype.

Graph comparing the relative activity of nucleases across different salt concentrations

Fig 5. Remaining host-cell DNA after nuclease treatment (37 °C, 1 h) across five enzyme amounts per 150 million HEK293 cells

The previous process using a conventional S. marcescens nuclease at physiological salt was compared with SAN HQ at 500 mM NaCl. DNA was quantified with Quant-iT dsDNA HS and normalized to pre-treatment samples. A process-to-process comparison, not a like-for-like enzyme test.

In ArcticZymes model studies, SAN HQ also removed DNA efficiently when added with a 500 mM salt lysis buffer directly to HEK293 cells in culture medium.

The chromatin evidence from enveloped virusescarries over in: the acib measles virus study, salt-active nuclease treatment removed chromatin to below detection in the flow-through, where two conventional nucleases left a clear chromatin band.

‍

What it means for your cost per dose

>70%

Lower nuclease cost

Modeled per batch

42%

Lower COGS per dose

Modeled AAV2 process

‍

Modeled AAV scenario: 2,000 L AAV2 process, 1×10¹⁴ VG/L titer, 44% overall recovery, SAN HQ compared with two conventional nucleases. Absolute costs vary by process. Download the whitepaper for the full model, the AAV and lentiviral scenarios, and the independent data behind them.

‍

Ready to evaluate in process?

Use our starting protocols for M-SAN HQ at physiological salt or SAN HQ at high salt.

No items found.
Fig .  

Application Background

Your DNA result may not reflect your chromatin reality

Most residual DNA assays measure accessible DNA,so chromatin-bound DNA can be under-reported — a nuclease that looks adequate on a standard assay may still leave nucleosome-protected DNA that effects filtration, purification and recovery. The same effect reaches genome titering:for qPCR or ddPCR, HL-SAN (the research and analytical grade SAN HQ) removes free and chromatin DNA while intact capsids protect the vector genome, giving a cleaner, more accurate titer. Learn more in our webinar: Your Viral Vector Analytics May Not Reflect Process Reality.

Host-cell DNA also carries CpG motifs that can trigger innate immune responses, and extra-viral DNA can vary from lot to lot without showing up in titer measurements.

M-SAN HQ and SAN HQ are made in Norway under an ISO 13485:2016 certified quality management system, from raw materials of certified non-animal origin. They are ancillary materials and are not intended to be part of the final drug product.

Quotation Mark

“Given its optimal activity in high salt conditions, SAN HQ improves downstream processes and reduces purification time without loss of vector yield and activity. SAN HQ’s improved efficiency is serotype independent.”

Lab Director, viral vector core at a major academic centre in the mid-Atlantic region (US)